With increasing revenues, the cannabis industry is investing more in modern cultivation techniques and controlled agricultural practices. This includes using advanced growing systems such as hydroponics and aeroponics and applying genetic engineering to create new strains with specific desired characteristics. The industry is also focusing on sustainability and ethics, with precision irrigation methods, development of biologically derived pesticide products, energy efficiency, and closed-loop cannabis extraction systems being areas of active research. Moreover, there’s a growing focus on standardization and quality control in cannabis cultivation, including using good agricultural practices, good manufacturing practices, regular testing, and personnel training.

Alongside CBD, THC is gaining recognition for its medical benefits. THC, the component known for its psychoactive effects, is also valuable for its therapeutic properties. It is utilized in FDA approved medications for nausea induced by cancer treatments and appetite stimulation in AIDS. Research into THC includes its potential to alleviate symptoms of multiple sclerosis, chronic pain, and glaucoma. As the cannabis industry continues to mature, the development of strains with a balance of CBD and THC is poised to enhance therapeutic outcomes for a broader range of medical conditions.

CBD, a non-psychoactive compound in cannabis, has gained attention for its potential benefits in treating depression, anxiety, PTSD, Alzheimer’s disease, and pain. Ongoing clinical trials are evaluating the efficacy of CBD in treating substance use disorders, including cannabis, opioid, alcohol, and cocaine use disorders. Research is also directed towards developing high CBD, low THC cannabis strains through molecular breeding to further medical applications.